Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents
A series of novel 1,2,3-triazole-dithiocarbamate hybrids were designed, synthesized and evaluated for anticancer activity against four selected human tumor cell lines (MGC-803, MCF-7, PC-3, EC-109). Majority of the synthesized compounds exhibited moderate to potent activity against MGC-803 and MCF-7...
Saved in:
Published in | European journal of medicinal chemistry Vol. 62; pp. 11 - 19 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
ISSY-LES-MOULINEAUX
Elsevier
01.04.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A series of novel 1,2,3-triazole-dithiocarbamate hybrids were designed, synthesized and evaluated for anticancer activity against four selected human tumor cell lines (MGC-803, MCF-7, PC-3, EC-109). Majority of the synthesized compounds exhibited moderate to potent activity against MGC-803 and MCF-7. Among them, compounds 3a and 3c showed excellent broad spectrum anticancer activity with IC50 values ranging from 0.73 to 11.61 mu M and 0.49-12.45 mu M, respectively. Particularly, compound 3a was more potent than 5-fluorouracil against all tested human cancer cell lines. Flow cytometry analysis demonstrated that treatment of MGC-803 with 3c led to cell cycle arrest at G2/M phase accompanied by an increase in apoptotic cell death after 12 h. (C) 2013 Elsevier Masson SAS. All rights reserved. |
---|---|
AbstractList | A series of novel 1,2,3-triazole-dithiocarbamate hybrids were designed, synthesized and evaluated for anticancer activity against four selected human tumor cell lines (MGC-803, MCF-7, PC-3, EC-109). Majority of the synthesized compounds exhibited moderate to potent activity against MGC-803 and MCF-7. Among them, compounds 3a and 3c showed excellent broad spectrum anticancer activity with IC50 values ranging from 0.73 to 11.61 μM and 0.49-12.45 μM, respectively. Particularly, compound 3a was more potent than 5-fluorouracil against all tested human cancer cell lines. Flow cytometry analysis demonstrated that treatment of MGC-803 with 3c led to cell cycle arrest at G2/M phase accompanied by an increase in apoptotic cell death after 12 h.A series of novel 1,2,3-triazole-dithiocarbamate hybrids were designed, synthesized and evaluated for anticancer activity against four selected human tumor cell lines (MGC-803, MCF-7, PC-3, EC-109). Majority of the synthesized compounds exhibited moderate to potent activity against MGC-803 and MCF-7. Among them, compounds 3a and 3c showed excellent broad spectrum anticancer activity with IC50 values ranging from 0.73 to 11.61 μM and 0.49-12.45 μM, respectively. Particularly, compound 3a was more potent than 5-fluorouracil against all tested human cancer cell lines. Flow cytometry analysis demonstrated that treatment of MGC-803 with 3c led to cell cycle arrest at G2/M phase accompanied by an increase in apoptotic cell death after 12 h. A series of novel 1,2,3-triazole-dithiocarbamate hybrids were designed, synthesized and evaluated for anticancer activity against four selected human tumor cell lines (MGC-803, MCF-7, PC-3, EC-109). Majority of the synthesized compounds exhibited moderate to potent activity against MGC-803 and MCF-7. Among them, compounds 3a and 3c showed excellent broad spectrum anticancer activity with IC50 values ranging from 0.73 to 11.61 mu M and 0.49-12.45 mu M, respectively. Particularly, compound 3a was more potent than 5-fluorouracil against all tested human cancer cell lines. Flow cytometry analysis demonstrated that treatment of MGC-803 with 3c led to cell cycle arrest at G2/M phase accompanied by an increase in apoptotic cell death after 12 h. (C) 2013 Elsevier Masson SAS. All rights reserved. A series of novel 1,2,3-triazole-dithiocarbamate hybrids were designed, synthesized and evaluated for anticancer activity against four selected human tumor cell lines (MGC-803, MCF-7, PC-3, EC-109). Majority of the synthesized compounds exhibited moderate to potent activity against MGC-803 and MCF-7. Among them, compounds 3a and 3c showed excellent broad spectrum anticancer activity with IC50 values ranging from 0.73 to 11.61 μM and 0.49-12.45 μM, respectively. Particularly, compound 3a was more potent than 5-fluorouracil against all tested human cancer cell lines. Flow cytometry analysis demonstrated that treatment of MGC-803 with 3c led to cell cycle arrest at G2/M phase accompanied by an increase in apoptotic cell death after 12 h. |
Author | Zhang, En Liu, Hong-Min Ye, Xian-Wei Duan, Ying-Chao Shi, Xiao-Jing Ma, Yong-Cheng Wang, Meng-Meng |
Author_xml | – sequence: 1 givenname: Ying-Chao surname: Duan fullname: Duan, Ying-Chao – sequence: 2 givenname: Yong-Cheng surname: Ma fullname: Ma, Yong-Cheng – sequence: 3 givenname: En surname: Zhang fullname: Zhang, En – sequence: 4 givenname: Xiao-Jing surname: Shi fullname: Shi, Xiao-Jing – sequence: 5 givenname: Meng-Meng surname: Wang fullname: Wang, Meng-Meng – sequence: 6 givenname: Xian-Wei surname: Ye fullname: Ye, Xian-Wei – sequence: 7 givenname: Hong-Min surname: Liu fullname: Liu, Hong-Min |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23353743$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUuLFDEUhYOMOD2j_0AkS8GpNq-qSrmT9gkDbmYfbiW3ptNUJW2SVtpfb4buceFCDBdCku-ccO-5IhchBiTkJWdrznj3drfG3YJ2uxaMi3UtpronZMX7TjdStOqCrJgQsmmFVJfkKucdY6ztGHtGLoWUreyVXBH7AbO_DxSCo_kYyrYeM40TDfEHzpTfiBvZlOThV5yxcb5sfbSQRligIN0ex-RdppDpPhYMxcNcrYq3ECwmCvf1Lj8nTyeYM74479fk7tPHu82X5vbb56-b97eNlb0sTcfcxNzYMa3sIPoWNFe1tQEkV27ASTotR8d7RDEMtpdWj-DQqnEAPWiQ1-T1yXaf4vcD5mIWny3OMwSMh2x4nYqUvG9ZRV-d0cO4oDP75BdIR_M4lwq8OQE_cYxTth5rP3-wOkjJddtXq7pEpfX_0xtfoPgYNvEQSpW-O0ltijknnIw9v5cEfjacmYe0zc6c0jYPaZtaNe0qVn-JH__8p-w3l6WujQ |
CitedBy_id | crossref_primary_10_3389_fchem_2022_969559 crossref_primary_10_1002_jssc_70083 crossref_primary_10_1016_j_ejmech_2015_02_030 crossref_primary_10_1002_slct_202101035 crossref_primary_10_1007_s10965_024_04014_3 crossref_primary_10_1016_j_bioorg_2019_03_003 crossref_primary_10_1007_s12010_019_03030_0 crossref_primary_10_1016_j_ejmech_2016_08_062 crossref_primary_10_1002_cbic_202400561 crossref_primary_10_1016_j_ejmech_2017_10_037 crossref_primary_10_1039_C7NJ01469D crossref_primary_10_3390_ph15091071 crossref_primary_10_1016_j_molstruc_2018_11_027 crossref_primary_10_1021_acs_joc_8b00206 crossref_primary_10_1039_C6RA24662A crossref_primary_10_3109_14756366_2014_922554 crossref_primary_10_1016_j_heliyon_2023_e19327 crossref_primary_10_3390_molecules25071607 crossref_primary_10_3389_fchem_2021_774977 crossref_primary_10_1016_j_ejmech_2015_05_016 crossref_primary_10_1039_C6OB00815A crossref_primary_10_1080_15257770_2014_955192 crossref_primary_10_2174_1570178617999200602151152 crossref_primary_10_1002_ejoc_201600740 crossref_primary_10_1134_S1070428023070096 crossref_primary_10_1016_j_ejmech_2018_08_056 crossref_primary_10_2174_1871520622666220412133112 crossref_primary_10_1016_j_ejmech_2017_09_038 crossref_primary_10_1016_j_ejmech_2015_02_026 crossref_primary_10_1002_med_21334 crossref_primary_10_1039_D4MD00617H crossref_primary_10_1007_s10528_015_9691_z crossref_primary_10_1007_s00044_019_02356_y crossref_primary_10_1016_j_ejmech_2014_03_018 crossref_primary_10_1016_j_compbiolchem_2019_01_013 crossref_primary_10_1002_jhet_2224 crossref_primary_10_1039_C9RA09510A crossref_primary_10_1107_S2414314616017120 crossref_primary_10_1016_j_cbi_2021_109688 crossref_primary_10_1016_j_tetlet_2014_11_069 crossref_primary_10_3390_molecules21020230 crossref_primary_10_1016_j_ica_2019_05_031 crossref_primary_10_1002_ardp_202000071 crossref_primary_10_1016_j_bmcl_2014_10_015 crossref_primary_10_1517_17460441_2016_1135125 crossref_primary_10_1002_ardp_201500175 crossref_primary_10_1016_j_ejmech_2019_111700 crossref_primary_10_1016_j_ejmech_2021_113602 crossref_primary_10_1039_C4NJ01565G crossref_primary_10_1039_C6RA13949C crossref_primary_10_1186_s43094_021_00241_3 crossref_primary_10_1007_s00044_024_03212_4 crossref_primary_10_1016_j_checat_2021_09_016 crossref_primary_10_1080_08927022_2023_2256624 crossref_primary_10_3184_174751917X15094552081189 crossref_primary_10_1016_j_bmc_2013_10_001 crossref_primary_10_1016_j_ejmech_2014_03_022 crossref_primary_10_1038_s41598_021_83069_4 crossref_primary_10_1039_C7MD00165G crossref_primary_10_1111_jphp_12474 crossref_primary_10_3390_molecules21121626 crossref_primary_10_1007_s10593_015_1672_y crossref_primary_10_1016_j_bmcl_2014_09_079 crossref_primary_10_1016_j_ejmech_2014_08_010 crossref_primary_10_1007_s13738_021_02231_x crossref_primary_10_3390_ph16020299 crossref_primary_10_1016_j_bioorg_2019_04_004 crossref_primary_10_1016_j_bmcl_2015_04_009 crossref_primary_10_1016_j_bmcl_2013_12_005 crossref_primary_10_1016_j_bmcl_2017_08_021 crossref_primary_10_1016_j_jlumin_2015_07_016 crossref_primary_10_1515_znb_2016_0065 crossref_primary_10_1007_s11030_017_9773_4 crossref_primary_10_1016_j_molliq_2024_125501 crossref_primary_10_1016_j_bmcl_2017_10_074 crossref_primary_10_1080_14756366_2017_1363197 crossref_primary_10_1002_ejoc_202001620 crossref_primary_10_1021_acs_chemrestox_9b00392 crossref_primary_10_1007_s00044_016_1622_y crossref_primary_10_1016_j_ejmech_2019_111698 crossref_primary_10_1016_j_ejmech_2022_114606 crossref_primary_10_1515_hc_2022_0174 crossref_primary_10_1039_D1RA08216G crossref_primary_10_1016_j_bmcl_2017_07_008 crossref_primary_10_1016_j_ejmech_2013_03_058 crossref_primary_10_1021_acs_orglett_5b03179 crossref_primary_10_1515_znb_2021_0146 crossref_primary_10_3390_cryst11091076 crossref_primary_10_1016_j_ejmcr_2022_100042 crossref_primary_10_1039_D0RA06251K crossref_primary_10_1016_j_bmcl_2016_12_030 crossref_primary_10_1016_j_ijporl_2017_02_028 crossref_primary_10_1177_1747519820966971 crossref_primary_10_22159_ijpps_2021v13i10_41882 crossref_primary_10_1016_j_bmcl_2018_11_036 crossref_primary_10_1016_j_ejmech_2016_08_049 crossref_primary_10_1039_C6RA28525B crossref_primary_10_3389_fchem_2022_926723 crossref_primary_10_2139_ssrn_4094639 crossref_primary_10_1021_acs_chemrev_6b00801 crossref_primary_10_1007_s12039_017_1318_y crossref_primary_10_1016_j_ejmech_2016_08_039 crossref_primary_10_1016_j_bioorg_2020_104606 crossref_primary_10_1021_acsami_1c08267 crossref_primary_10_1002_slct_202300238 crossref_primary_10_1039_C9NJ00473D crossref_primary_10_1134_S1070363217060251 crossref_primary_10_3390_molecules18077661 crossref_primary_10_1002_ajoc_202200355 crossref_primary_10_1016_j_ejmech_2018_02_033 crossref_primary_10_1002_ardp_202400271 crossref_primary_10_1016_j_bioorg_2018_03_002 crossref_primary_10_1002_aoc_7515 crossref_primary_10_1002_slct_202003684 crossref_primary_10_1134_S1070428023110118 crossref_primary_10_1002_slct_201802875 crossref_primary_10_1002_slct_202003680 crossref_primary_10_2174_0113816128271288231023045049 crossref_primary_10_1016_j_ejmech_2019_111885 crossref_primary_10_1007_s13738_019_01644_z crossref_primary_10_3389_fddsv_2022_1072448 crossref_primary_10_1016_j_ejmech_2016_09_023 crossref_primary_10_1016_j_bmc_2021_116331 crossref_primary_10_1016_j_ejmech_2017_04_056 crossref_primary_10_1016_j_ejmech_2017_11_009 crossref_primary_10_1002_jccs_201700129 crossref_primary_10_1016_j_bioorg_2024_107670 crossref_primary_10_1039_C8DT04189J crossref_primary_10_1039_C9RA00630C crossref_primary_10_1039_D4QO01334D crossref_primary_10_2174_2212796814999200807214519 crossref_primary_10_1080_14756366_2023_2290461 crossref_primary_10_1016_j_arabjc_2024_105872 crossref_primary_10_1016_j_bioorg_2024_107556 crossref_primary_10_1080_14756366_2017_1414807 crossref_primary_10_1186_s13065_023_01072_4 crossref_primary_10_1039_C4MD00283K crossref_primary_10_1007_s00044_016_1721_9 crossref_primary_10_1039_C4RA05080K crossref_primary_10_1016_j_cveq_2020_03_010 crossref_primary_10_1016_j_jscs_2015_03_003 crossref_primary_10_1016_j_ejmcr_2023_100113 crossref_primary_10_1080_10406638_2014_957404 crossref_primary_10_3390_molecules29020550 crossref_primary_10_1039_C3CP54609H crossref_primary_10_1039_D4OB00749B crossref_primary_10_1016_j_bmc_2015_10_042 crossref_primary_10_1016_j_ejmech_2014_02_063 crossref_primary_10_1016_j_ejmech_2015_07_026 crossref_primary_10_1016_j_ejmech_2018_01_020 crossref_primary_10_1002_slct_202403149 crossref_primary_10_1016_j_bmcl_2016_08_060 crossref_primary_10_1016_j_bioorg_2019_103299 crossref_primary_10_1016_j_ijbiomac_2022_04_140 crossref_primary_10_1016_j_ejmech_2019_04_073 crossref_primary_10_3184_174751916X14597828245275 crossref_primary_10_3390_molecules20058666 crossref_primary_10_1002_ardp_201800204 crossref_primary_10_1039_C7RA02720F crossref_primary_10_1016_j_bmc_2018_06_026 crossref_primary_10_1021_jm401002r crossref_primary_10_1039_C8GC01516C crossref_primary_10_1016_j_jorganchem_2018_01_049 crossref_primary_10_1002_jhet_4545 crossref_primary_10_21597_jist_1322222 crossref_primary_10_1039_C5RA25519H crossref_primary_10_2174_1573406415666190416121448 crossref_primary_10_3390_molecules24234388 crossref_primary_10_1039_C4MD00031E crossref_primary_10_2174_2213335607666200226102010 crossref_primary_10_1016_j_bmcl_2013_12_095 crossref_primary_10_1016_j_jics_2021_100105 crossref_primary_10_1016_j_molstruc_2016_07_076 crossref_primary_10_1590_1519_6984_255529 crossref_primary_10_1016_j_ejmech_2016_06_011 crossref_primary_10_1002_ejoc_202200317 crossref_primary_10_1039_C9NJ03802G crossref_primary_10_14233_ajchem_2019_21655 crossref_primary_10_1016_j_ejmech_2019_111840 crossref_primary_10_2174_2213335609666220118102344 crossref_primary_10_1016_j_jiec_2017_10_045 crossref_primary_10_1016_j_jorganchem_2019_06_013 crossref_primary_10_1016_j_bmc_2022_116874 crossref_primary_10_1016_j_molstruc_2022_133317 crossref_primary_10_1002_aoc_5426 crossref_primary_10_1016_j_ejmech_2016_12_014 crossref_primary_10_1016_j_bmcl_2014_12_087 crossref_primary_10_1111_php_13834 crossref_primary_10_1002_slct_201800134 crossref_primary_10_1016_j_molstruc_2024_138444 crossref_primary_10_1007_s11164_016_2575_y crossref_primary_10_1016_j_ejmech_2019_111739 crossref_primary_10_1002_jhet_3112 crossref_primary_10_1021_sc400426x crossref_primary_10_1016_j_ejmech_2016_02_059 crossref_primary_10_1002_slct_201701241 crossref_primary_10_1016_j_steroids_2021_108950 crossref_primary_10_3390_molecules28031084 crossref_primary_10_1016_j_ccr_2016_02_010 crossref_primary_10_1016_j_ejmech_2018_01_055 crossref_primary_10_1016_j_ejmech_2016_12_027 crossref_primary_10_1016_j_ejmech_2017_08_042 crossref_primary_10_1007_s00044_020_02599_0 crossref_primary_10_1016_j_rechem_2021_100132 crossref_primary_10_1080_10406638_2020_1718717 crossref_primary_10_2174_1574892815666200717164457 crossref_primary_10_1039_C9RA03425K crossref_primary_10_1007_s11164_015_2241_9 crossref_primary_10_1002_cmdc_202400297 crossref_primary_10_1016_j_compbiolchem_2022_107641 crossref_primary_10_1016_j_molstruc_2019_127097 crossref_primary_10_1080_10406638_2023_2247119 crossref_primary_10_1016_j_bioorg_2024_108106 crossref_primary_10_1007_s10870_014_0504_8 crossref_primary_10_3390_molecules19022523 crossref_primary_10_1080_00958972_2022_2059359 crossref_primary_10_1515_znc_2020_0104 crossref_primary_10_1007_s11164_017_2955_y crossref_primary_10_1002_ardp_202000164 |
Cites_doi | 10.1016/j.bmc.2006.08.019 10.1021/cc800090d 10.1021/jm300125e 10.1016/j.bmcl.2008.07.087 10.3987/COM-11-12147 10.1016/j.ejmech.2011.01.050 10.1021/jm0509288 10.1016/j.bmc.2007.08.020 10.1016/j.ejmech.2011.02.016 10.1021/jm051118z 10.1021/jm00356a025 10.1021/ol802286g 10.1039/c2cc16395k 10.1002/asia.201100432 10.1016/j.bmcl.2011.04.096 10.1002/ejoc.200700475 10.1016/j.bmc.2010.04.091 10.1021/jm1000979 10.1021/jf950751y 10.1021/jo702023s 10.1016/j.ejmech.2010.07.031 10.1021/jm050408c 10.1016/j.ejmech.2010.08.012 10.7164/antibiotics.44.969 10.1002/anie.200502161 10.1016/j.bmc.2008.03.049 10.1021/jm100246m 10.1016/j.bmcl.2008.01.102 10.1016/j.bmcl.2010.05.014 10.1039/C0CC02472D 10.1016/j.bmcl.2008.12.026 10.1016/S1359-6446(03)02933-7 10.1021/jm101238d 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4 10.1021/jm300031j 10.1021/jm901757t 10.1016/S0090-9556(25)07432-X 10.1016/S0968-0896(01)00044-X 10.1016/j.ejmech.2011.10.033 10.1016/j.ejmech.2011.06.007 10.1021/jm060754+ 10.1016/j.ejmech.2009.04.004 10.1016/j.bmcl.2012.03.018 10.1021/jm001124p 10.1039/b616751a 10.1016/j.bmcl.2011.03.029 10.1021/jm800149m 10.1016/j.bmc.2008.09.071 10.1039/c0cc02472d 10.1002/ijc.25684 |
ContentType | Journal Article |
Copyright | Copyright © 2013 Elsevier Masson SAS. All rights reserved. |
Copyright_xml | – notice: Copyright © 2013 Elsevier Masson SAS. All rights reserved. |
DBID | AAYXX CITATION 17B 1KM BLEPL DTL EGQ GKMDS CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.ejmech.2012.12.046 |
DatabaseName | CrossRef Web of Knowledge Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science Primary (SCIE, SSCI & AHCI) Web of Science - Science Citation Index Expanded - 2013 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef Web of Science MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Web of Science MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1768-3254 |
EndPage | 19 |
ExternalDocumentID | 23353743 000318577500002 10_1016_j_ejmech_2012_12_046 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: China Postdoctoral Science Foundation grantid: 20100480857; 201104402 – fundername: New Teachers' Fund for Doctor Stations, Ministry of Education grantid: 20114101120013 – fundername: National Natural Science Foundation of China; National Natural Science Foundation of China (NSFC) grantid: 81172937; U1204206 |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 29G 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM 9JN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARLI AATTM AAXKI AAXUO AAYOK AAYWO AAYXX ABFNM ABFRF ABGSF ABJNI ABMAC ABOCM ABUDA ABWVN ABXDB ABZDS ACDAQ ACGFO ACIUM ACNNM ACRLP ACRPL ACVFH ADBBV ADCNI ADECG ADEZE ADMUD ADNMO ADUVX AEBSH AEFWE AEHWI AEIPS AEKER AENEX AEUPX AFJKZ AFPUW AFTJW AFXIZ AFZHZ AGCQF AGHFR AGQPQ AGRDE AGRNS AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJSZI AKBMS AKRWK AKYEP ALCLG ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CITATION CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FLBIZ FNPLU FYGXN G-2 G-Q GBLVA HMS HMT HVGLF HZ~ IHE J1W KOM M2Y M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCB SCC SDF SDG SES SEW SOC SPC SPCBC SPT SSH SSK SSP SSU SSZ T5K WUQ ~G- 17B 1KM BLEPL DTL EFKBS GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED GROUPED_WOS_WEB_OF_SCIENCE CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c373t-60df0db6084c9275a8140129a314d9ef3d83bd17ee299c73c8badec4b9a898a3 |
ISICitedReferencesCount | 260 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000318577500002 |
ISSN | 0223-5234 1768-3254 |
IngestDate | Fri Jul 11 06:47:45 EDT 2025 Mon Jul 21 06:03:25 EDT 2025 Wed Aug 06 06:37:00 EDT 2025 Fri Aug 29 16:06:01 EDT 2025 Tue Jul 01 05:08:41 EDT 2025 Thu Apr 24 22:58:35 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | ANALOGS ANTIFUNGAL ACTIVITY Hybrid Cell cycle arrest ANTITUMOR-ACTIVITY CANCER 1,2,3-TRIAZOLES BIOLOGICAL EVALUATION Dithiocarbamate HIV-1 PROTEASE INHIBITORS Anticancer 1,2,3-triazole DERIVATIVES Apoptosis |
Language | English |
License | Copyright © 2013 Elsevier Masson SAS. All rights reserved. |
LinkModel | OpenURL |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-c373t-60df0db6084c9275a8140129a314d9ef3d83bd17ee299c73c8badec4b9a898a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-4818-756X |
PMID | 23353743 |
PQID | 1325331750 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | pubmed_primary_23353743 webofscience_primary_000318577500002 webofscience_primary_000318577500002CitationCount proquest_miscellaneous_1325331750 crossref_citationtrail_10_1016_j_ejmech_2012_12_046 crossref_primary_10_1016_j_ejmech_2012_12_046 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-04-00 2013-04-01 2013-Apr 20130401 |
PublicationDateYYYYMMDD | 2013-04-01 |
PublicationDate_xml | – month: 04 year: 2013 text: 2013-04-00 |
PublicationDecade | 2010 |
PublicationPlace | ISSY-LES-MOULINEAUX |
PublicationPlace_xml | – name: ISSY-LES-MOULINEAUX – name: France |
PublicationTitle | European journal of medicinal chemistry |
PublicationTitleAbbrev | EUR J MED CHEM |
PublicationTitleAlternate | Eur J Med Chem |
PublicationYear | 2013 |
Publisher | Elsevier |
Publisher_xml | – name: Elsevier |
References | Buckle (10.1016/j.ejmech.2012.12.046_bib10) 1983; 26 Vatmurge (10.1016/j.ejmech.2012.12.046_bib4) 2008; 18 Patpi (10.1016/j.ejmech.2012.12.046_bib14) 2012; 55 Agalave (10.1016/j.ejmech.2012.12.046_bib2) 2011; 6 Wang (10.1016/j.ejmech.2012.12.046_bib9) 2010; 45 Reddy (10.1016/j.ejmech.2012.12.046_bib27) 2011; 46 Stefely (10.1016/j.ejmech.2012.12.046_bib30) 2010; 53 Bennet (10.1016/j.ejmech.2012.12.046_bib16) 1991; 44 Cristina (10.1016/j.ejmech.2012.12.046_bib41) 2011; 12 Zahran (10.1016/j.ejmech.2012.12.046_bib37) 2008; 16 Carta (10.1016/j.ejmech.2012.12.046_bib33) 2012; 55 Soltis (10.1016/j.ejmech.2012.12.046_bib17) 1996; 24 Ronconi (10.1016/j.ejmech.2012.12.046_bib40) 2006; 49 Imamura (10.1016/j.ejmech.2012.12.046_bib32) 2001; 9 Singh (10.1016/j.ejmech.2012.12.046_bib29) 2012; 47 Giffin (10.1016/j.ejmech.2012.12.046_bib12) 2008; 51 Brahemi (10.1016/j.ejmech.2012.12.046_bib43) 2010; 53 Jawalekar (10.1016/j.ejmech.2012.12.046_bib48) 2008; 73 Simone (10.1016/j.ejmech.2012.12.046_bib15) 2011; 54 Demaray (10.1016/j.ejmech.2012.12.046_bib8) 2008; 18 Wang (10.1016/j.ejmech.2012.12.046_bib45) 2011; 83 Len (10.1016/j.ejmech.2012.12.046_bib31) 1996; 44 Aher (10.1016/j.ejmech.2012.12.046_bib7) 2009; 19 Whiting (10.1016/j.ejmech.2012.12.046_bib11) 2006; 4 Huang (10.1016/j.ejmech.2012.12.046_bib35) 2009; 44 Odlo (10.1016/j.ejmech.2012.12.046_bib28) 2008; 16 Wang (10.1016/j.ejmech.2012.12.046_bib44) 2011; 21 Li (10.1016/j.ejmech.2012.12.046_bib38) 2011; 21 Khan (10.1016/j.ejmech.2012.12.046_bib39) 2011; 46 Bock (10.1016/j.ejmech.2012.12.046_bib6) 2007; 5 Kallander (10.1016/j.ejmech.2012.12.046_bib20) 2005; 48 Lin (10.1016/j.ejmech.2012.12.046_bib49) 2007; 26 Fray (10.1016/j.ejmech.2012.12.046_bib18) 2001; 24 Carta (10.1016/j.ejmech.2012.12.046_bib34) 2012; 48 Whiting (10.1016/j.ejmech.2012.12.046_bib5) 2006; 45 Yoon (10.1016/j.ejmech.2012.12.046_bib24) 2010; 20 Costa (10.1016/j.ejmech.2012.12.046_bib13) 2006; 14 Qian (10.1016/j.ejmech.2012.12.046_bib36) 2010; 18 Hu (10.1016/j.ejmech.2012.12.046_bib47) 2008; 10 Cafici (10.1016/j.ejmech.2012.12.046_bib22) 2008; 10 Yim (10.1016/j.ejmech.2012.12.046_bib23) 2010; 53 Imperio (10.1016/j.ejmech.2012.12.046_bib19) 2007; 15 Wilkening (10.1016/j.ejmech.2012.12.046_bib46) 2011; 47 Rostovtsev (10.1016/j.ejmech.2012.12.046_bib3) 2002; 41 Bacharaju (10.1016/j.ejmech.2012.12.046_bib42) 2012; 22 Kolb (10.1016/j.ejmech.2012.12.046_bib1) 2009; 8 Pagliai (10.1016/j.ejmech.2012.12.046_bib21) 2006; 49 Vantikommu (10.1016/j.ejmech.2012.12.046_bib25) 2010; 45 Li (10.1016/j.ejmech.2012.12.046_bib26) 2011; 45 Agalave, SG (WOS:000296273900010) 2011; 6 Qian, Y (WOS:000278480900015) 2010; 18 Whiting, M (WOS:000235628700022) 2006; 45 Wang, XL (WOS:000282112700027) 2010; 45 Yoon, J (WOS:000278644700021) 2010; 20 Imperio, D (WOS:000250179600014) 2007; 15 Jawalekar, AM (WOS:000252046600040) 2008; 73 Cafici, L (WOS:000259033500020) 2008; 10 Kolb, HC (WOS:000187217100009) 2003; 8 Wilkening, I (WOS:000285068300070) 2011; 47 Imamura, H (WOS:000169404600020) 2001; 9 Hu, MY (WOS:000261613700008) 2008; 10 Li, XL (WOS:000289048400031) 2011; 46 Li, RD (WOS:000291145900027) 2011; 21 Singh, P (WOS:000301169800064) 2012; 47 Bock, VD (WOS:000244703800014) 2007; 5 Wang, XJ (WOS:000290024200060) 2011; 21 Reddy, DM (WOS:000291118600004) 2011; 46 Patpi, SR (WOS:000303173600024) 2012; 55 Len, C (WOS:A1996VH80700074) 1996; 44 Odlo, K (WOS:000255605600005) 2008; 16 Aher, NG (WOS:000262707000040) 2009; 19 Zahran, MAH (WOS:000260758200009) 2008; 16 Bacharaju, K (WOS:000302964300047) 2012; 22 Demaray, JA (WOS:000259144900026) 2008; 18 BUCKLE, DR (WOS:A1983PZ65200025) 1983; 26 Brahemi, G (WOS:000276096300006) 2010; 53 Vantikommu, J (WOS:000283911300042) 2010; 45 Whiting, M (WOS:000242974100016) 2006; 49 De Simone, R (WOS:000288400700003) 2011; 54 Soltis, MJ (WOS:A1996UW90000016) 1996; 24 Marzano, C (WOS:000291603900023) 2011; 129 BENNETT, IS (WOS:A1991GM54900008) 1991; 44 Yim, CB (WOS:000277766900009) 2010; 53 Stefely, JA (WOS:000276562400032) 2010; 53 Vatmurge, NS (WOS:000254180300055) 2008; 18 Costa, MS (WOS:000242454700049) 2006; 14 Pagliai, F (WOS:000234836200008) 2006; 49 Rostovtsev, VV (WOS:000176972000038) 2002; 41 Carta, F (WOS:000301156000025) 2012; 55 Khan, H (WOS:000295237400056) 2011; 46 Giffin, MJ (WOS:000260102700004) 2008; 51 Kallander, LS (WOS:000231743000003) 2005; 48 Carta, F (WOS:000299112500008) 2012; 48 Ronconi, L (WOS:000236005400016) 2006; 49 Fray, MJ (WOS:000169047400011) 2001; 44 Wang, XJ (WOS:000291084400002) 2011; 83 Lin, WY (WOS:000249797200004) 2007; 2007 Huang, W (WOS:000268744700041) 2009; 44 |
References_xml | – volume: 14 start-page: 8644 year: 2006 ident: 10.1016/j.ejmech.2012.12.046_bib13 article-title: Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2006.08.019 – volume: 10 start-page: 732 year: 2008 ident: 10.1016/j.ejmech.2012.12.046_bib22 article-title: Solution-phase parallel synthesis and biological evaluation of combretatriazoles publication-title: J. Comb. Chem. doi: 10.1021/cc800090d – volume: 55 start-page: 3911 year: 2012 ident: 10.1016/j.ejmech.2012.12.046_bib14 article-title: Design, Synthesis, and structure-activity correlations of novel dibenzo[b, d]furan, dibenzo[b, d]thiophene, and N-methylcarbazole clubbed 1,2,3-triazoles as potent inhibitors of mycobacterium tuberculosis publication-title: J. Med. Chem. doi: 10.1021/jm300125e – volume: 18 start-page: 4868 year: 2008 ident: 10.1016/j.ejmech.2012.12.046_bib8 article-title: Synthesis of triazole-oxazolidinones via a one-pot reaction and evaluation of their antimicrobial activity publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2008.07.087 – volume: 83 start-page: 1005 year: 2011 ident: 10.1016/j.ejmech.2012.12.046_bib45 article-title: Synthesis of various substituted spiro- and bicyclethiazolidine-2-thiones by a multicomponent reaction and biological evaluation in vitro publication-title: Hetrocycles doi: 10.3987/COM-11-12147 – volume: 45 start-page: 1274 year: 2011 ident: 10.1016/j.ejmech.2012.12.046_bib26 article-title: The novel anti-tumor agents of 4-triazol-1,8- naphthalimides: synthesis, cytotoxicity, DNA intercalation and photocleavage publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2011.01.050 – volume: 49 start-page: 1648 year: 2006 ident: 10.1016/j.ejmech.2012.12.046_bib40 article-title: Gold(III) dithiocarbamate derivatives for the treatment of Cancer: solution chemistry, DNA binding, and hemolytic properties publication-title: J. Med. Chem. doi: 10.1021/jm0509288 – volume: 15 start-page: 6748 year: 2007 ident: 10.1016/j.ejmech.2012.12.046_bib19 article-title: Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2007.08.020 – volume: 46 start-page: 1983 year: 2011 ident: 10.1016/j.ejmech.2012.12.046_bib27 article-title: 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2011.02.016 – volume: 49 start-page: 467 year: 2006 ident: 10.1016/j.ejmech.2012.12.046_bib21 article-title: Rapid synthesis of triazole-modified resveratrol analogues via click chemistry publication-title: J. Med. Chem. doi: 10.1021/jm051118z – volume: 26 start-page: 251 year: 1983 ident: 10.1016/j.ejmech.2012.12.046_bib10 article-title: Studies on v-triazoles. 7. Antiallergic 9-oxo- 1H,9H-benzopyrano[2,3-d]-v-triazoles publication-title: J. Med. Chem. doi: 10.1021/jm00356a025 – volume: 10 start-page: 5529 year: 2008 ident: 10.1016/j.ejmech.2012.12.046_bib47 article-title: In situ “Click” assembly of small molecule matrix metalloprotease inhibitors containing zinc-chelating groups publication-title: Org. Lett. doi: 10.1021/ol802286g – volume: 48 start-page: 1868 year: 2012 ident: 10.1016/j.ejmech.2012.12.046_bib34 article-title: Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations publication-title: Chem. Commun. doi: 10.1039/c2cc16395k – volume: 6 start-page: 2696 year: 2011 ident: 10.1016/j.ejmech.2012.12.046_bib2 article-title: Click chemistry: 1,2,3-triazoles as pharmacophores publication-title: Chem. Asian J. doi: 10.1002/asia.201100432 – volume: 21 start-page: 3636 year: 2011 ident: 10.1016/j.ejmech.2012.12.046_bib38 article-title: Novel EGFR inhibitors prepared by combination of dithiocarbamic acid esters and 4-anilinoquinazolines publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2011.04.096 – volume: 26 start-page: 4301 year: 2007 ident: 10.1016/j.ejmech.2012.12.046_bib49 article-title: Synthesis of meso-coumarin-conjugated porphyrins and investigation of their luminescence properties publication-title: Eur. J. Org. Chem. doi: 10.1002/ejoc.200700475 – volume: 18 start-page: 4310 year: 2010 ident: 10.1016/j.ejmech.2012.12.046_bib36 article-title: Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2010.04.091 – volume: 53 start-page: 3389 year: 2010 ident: 10.1016/j.ejmech.2012.12.046_bib30 article-title: N-((1-Benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell lines publication-title: J. Med. Chem. doi: 10.1021/jm1000979 – volume: 44 start-page: 2856 year: 1996 ident: 10.1016/j.ejmech.2012.12.046_bib31 article-title: Synthesis and antifungal activity of novel bis(dithiocarbamate) derivatives of glycerol publication-title: J. Agric. Food Chem. doi: 10.1021/jf950751y – volume: 73 start-page: 287 year: 2008 ident: 10.1016/j.ejmech.2012.12.046_bib48 article-title: Conjugation of nucleosides and oligonucleotides by [3+2] cycloaddition publication-title: J. Org. Chem. doi: 10.1021/jo702023s – volume: 45 start-page: 4631 year: 2010 ident: 10.1016/j.ejmech.2012.12.046_bib9 article-title: Synthesis of novel sulfanilamide-derived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2010.07.031 – volume: 48 start-page: 5644 year: 2005 ident: 10.1016/j.ejmech.2012.12.046_bib20 article-title: 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo publication-title: J. Med. Chem. doi: 10.1021/jm050408c – volume: 45 start-page: 5044 year: 2010 ident: 10.1016/j.ejmech.2012.12.046_bib25 article-title: Synthesis and cytotoxicity evaluation of novel 1,4-disubstituted 1,2,3-triazoles via CuI catalysed 1,3-dipolar cycloaddition publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2010.08.012 – volume: 44 start-page: 969 year: 1991 ident: 10.1016/j.ejmech.2012.12.046_bib16 article-title: 6-(substituted methylene) penems, potent broad spectrum inhibitors of bacterial β-Lactamse. V. chiral 1,2,3-triazolyl derivatives publication-title: J. Antibiot. doi: 10.7164/antibiotics.44.969 – volume: 45 start-page: 1435 year: 2006 ident: 10.1016/j.ejmech.2012.12.046_bib5 article-title: Inhibitors of HIV-1 protease by using in situ click chemistry publication-title: Angew. Chem. Int. Ed. doi: 10.1002/anie.200502161 – volume: 16 start-page: 4829 year: 2008 ident: 10.1016/j.ejmech.2012.12.046_bib28 article-title: 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2008.03.049 – volume: 53 start-page: 3944 year: 2010 ident: 10.1016/j.ejmech.2012.12.046_bib23 article-title: Synthesis of DOTA-conjugated multimeric [Tyr3]Octreotide peptides via a combination of Cu(I)- catalyzed "Click" cycloaddition and thio acid/sulfonyl azide "sulfo-click" amidation and their in vivo evaluation publication-title: J. Med.Chem. doi: 10.1021/jm100246m – volume: 18 start-page: 2043 year: 2008 ident: 10.1016/j.ejmech.2012.12.046_bib4 article-title: Synthesis and antimicrobial activity of β-lactam-bile acid conjugates linked via triazole publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2008.01.102 – volume: 20 start-page: 3930 year: 2010 ident: 10.1016/j.ejmech.2012.12.046_bib24 article-title: A rapid synthesis of lavendustin-mimetic small molecules by click fragment assembly publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2010.05.014 – volume: 47 start-page: 349 year: 2011 ident: 10.1016/j.ejmech.2012.12.046_bib46 article-title: Synthesis of phosphonamidate peptides by Staudinger reactions of silylated phosphinic acids and esters publication-title: Chem. Commun. doi: 10.1039/C0CC02472D – volume: 19 start-page: 759 year: 2009 ident: 10.1016/j.ejmech.2012.12.046_bib7 article-title: Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2008.12.026 – volume: 8 start-page: 1128 year: 2009 ident: 10.1016/j.ejmech.2012.12.046_bib1 article-title: The growing impact of click chemistry on drug discovery publication-title: Drug Discov. Today doi: 10.1016/S1359-6446(03)02933-7 – volume: 54 start-page: 1565 year: 2011 ident: 10.1016/j.ejmech.2012.12.046_bib15 article-title: Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1,5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents publication-title: J. Med. Chem. doi: 10.1021/jm101238d – volume: 41 start-page: 2596 year: 2002 ident: 10.1016/j.ejmech.2012.12.046_bib3 article-title: A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective “Ligation” of azides and terminal alkynes publication-title: Angew. Chem. Int. Ed. doi: 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4 – volume: 55 start-page: 1721 year: 2012 ident: 10.1016/j.ejmech.2012.12.046_bib33 article-title: Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo publication-title: J. Med. Chem. doi: 10.1021/jm300031j – volume: 53 start-page: 2757 year: 2010 ident: 10.1016/j.ejmech.2012.12.046_bib43 article-title: Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer publication-title: J. Med. Chem. doi: 10.1021/jm901757t – volume: 24 start-page: 799 year: 1996 ident: 10.1016/j.ejmech.2012.12.046_bib17 article-title: Identification and characterization of human metabolites of CAI [5-amino-1-1(4'-chlorobenzoyl-3,5-dichlorobenzyl)-1,2,3-triazole-4-carboxamide) publication-title: Drug Metab. Dispos doi: 10.1016/S0090-9556(25)07432-X – volume: 9 start-page: 1571 year: 2001 ident: 10.1016/j.ejmech.2012.12.046_bib32 article-title: Dicationic dithiocarbamate carbapenems with anti-MRSA activity publication-title: Bioorg. Med. Chem. doi: 10.1016/S0968-0896(01)00044-X – volume: 47 start-page: 594 year: 2012 ident: 10.1016/j.ejmech.2012.12.046_bib29 article-title: 1,2,3-Triazole tethered β-lactam-Chalcone bifunctional hybrids: synthesis and anticancer evaluation publication-title: Eur. J. Med.Chem doi: 10.1016/j.ejmech.2011.10.033 – volume: 46 start-page: 4071 year: 2011 ident: 10.1016/j.ejmech.2012.12.046_bib39 article-title: Synthesis, characterization and anticancer studies of mixed ligand dithiocarbamate palladium(II) complexes publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2011.06.007 – volume: 4 start-page: 7697 year: 2006 ident: 10.1016/j.ejmech.2012.12.046_bib11 article-title: Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization publication-title: J. Med. Chem. doi: 10.1021/jm060754+ – volume: 44 start-page: 3687 year: 2009 ident: 10.1016/j.ejmech.2012.12.046_bib35 article-title: Synthesis and antitumor activity of novel dithiocarbamate substituted chromones publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2009.04.004 – volume: 22 start-page: 3274 year: 2012 ident: 10.1016/j.ejmech.2012.12.046_bib42 article-title: Design, synthesis, molecular docking and biological evaluation of new dithiocarbamates substituted benzimidazole and chalcones as possible chemotherapeutic agents publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2012.03.018 – volume: 24 start-page: 1951 year: 2001 ident: 10.1016/j.ejmech.2012.12.046_bib18 article-title: Structure-activity relationships of 1,4-dihydro-(1H,4H)-quinoxaline-2,3-dionesas N-methyl-D-aspartate (glycine site) receptor antagonists. 1. Heterocyclic substituted 5-alkyl derivatives publication-title: J. Med. Chem. doi: 10.1021/jm001124p – volume: 5 start-page: 971 year: 2007 ident: 10.1016/j.ejmech.2012.12.046_bib6 article-title: 1,2,3-Triazoles as peptide bond isosteres: synthesis and biological evaluation of cyclotetrapeptide mimics publication-title: Org. Biomol. Chem. doi: 10.1039/b616751a – volume: 21 start-page: 3074 year: 2011 ident: 10.1016/j.ejmech.2012.12.046_bib44 article-title: Synthesis and in vitro antitumor activity of new butenolide-containing dithiocarbamates publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2011.03.029 – volume: 12 start-page: 487 year: 2011 ident: 10.1016/j.ejmech.2012.12.046_bib41 article-title: Gold(III)- dithiocarbamato anticancer agents: activity, toxicology and histopathological studies in rodents publication-title: Int. J. Cancer – volume: 51 start-page: 6263 year: 2008 ident: 10.1016/j.ejmech.2012.12.046_bib12 article-title: A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant publication-title: J. Med. Chem. doi: 10.1021/jm800149m – volume: 16 start-page: 9708 year: 2008 ident: 10.1016/j.ejmech.2012.12.046_bib37 article-title: Design, synthesis and antitumor evaluation of novel thalidomide dithiocarbamate and dithioate analogs against Ehrlich ascites carcinoma- induced solid tumor in Swiss albino mice publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2008.09.071 – volume: 55 start-page: 1721 year: 2012 ident: WOS:000301156000025 article-title: Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in Vivo publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm300031j – volume: 49 start-page: 7697 year: 2006 ident: WOS:000242974100016 article-title: Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm060754+ – volume: 46 start-page: 4071 year: 2011 ident: WOS:000295237400056 article-title: Synthesis, characterization and anticancer studies of mixed ligand dithiocarbamate palladium(II) complexes publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2011.06.007 – volume: 10 start-page: 5529 year: 2008 ident: WOS:000261613700008 article-title: In Situ "Click" Assembly of Small Molecule Matrix Metalloprotease Inhibitors Containing Zinc-Chelating Groups publication-title: ORGANIC LETTERS doi: 10.1021/ol802286g – volume: 49 start-page: 467 year: 2006 ident: WOS:000234836200008 article-title: Rapid synthesis of triazole-modified resveratrol analogues via click chemistry publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm051118z – volume: 53 start-page: 3944 year: 2010 ident: WOS:000277766900009 article-title: Synthesis of DOTA-Conjugated Multimeric [Tyr(3)]Octreotide Peptides via a Combination of Cu(I)-Catalyzed "Click" Cycloaddition and Thio Acid/Sulfonyl Azide "Sulfo-Click" Amidation and Their in Vivo Evaluation publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm100246m – volume: 2007 start-page: 4301 year: 2007 ident: WOS:000249797200004 article-title: Synthesis of meso-coumarin-conjugated Porphyrins and investigation of their luminescence properties publication-title: EUROPEAN JOURNAL OF ORGANIC CHEMISTRY – volume: 44 start-page: 3687 year: 2009 ident: WOS:000268744700041 article-title: Synthesis and antitumor activity of novel dithiocarbamate substituted chromones publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2009.04.004 – volume: 45 start-page: 5044 year: 2010 ident: WOS:000283911300042 article-title: Synthesis and cytotoxicity evaluation of novel 1,4-disubstituted 1,2,3-triazoles via CuI catalysed 1,3-dipolar cycloaddition publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2010.08.012 – volume: 47 start-page: 594 year: 2012 ident: WOS:000301169800064 article-title: 1,2,3-Triazole tethered beta-lactam-Chalcone bifunctional hybrids: Synthesis and anticancer evaluation publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2011.10.033 – volume: 22 start-page: 3274 year: 2012 ident: WOS:000302964300047 article-title: Design, synthesis, molecular docking and biological evaluation of new dithiocarbamates substituted benzimidazole and chalcones as possible chemotherapeutic agents publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS doi: 10.1016/j.bmcl.2012.03.018 – volume: 53 start-page: 3389 year: 2010 ident: WOS:000276562400032 article-title: N-((1-Benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a New Scaffold that Provides Rapid Access to Antimicrotubule Agents: Synthesis and Evaluation of Antiproliferative Activity Against Select Cancer Cell Lines publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm1000979 – volume: 16 start-page: 4829 year: 2008 ident: WOS:000255605600005 article-title: 1,5-disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin publication-title: BIOORGANIC & MEDICINAL CHEMISTRY doi: 10.1016/j.bmc.2008.03.049 – volume: 47 start-page: 349 year: 2011 ident: WOS:000285068300070 article-title: Synthesis of phosphonamidate peptides by Staudinger reactions of silylated phosphinic acids and esters publication-title: CHEMICAL COMMUNICATIONS doi: 10.1039/c0cc02472d – volume: 20 start-page: 3930 year: 2010 ident: WOS:000278644700021 article-title: A rapid synthesis of lavendustin-mimetic small molecules by click fragment assembly publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS doi: 10.1016/j.bmcl.2010.05.014 – volume: 44 start-page: 1951 year: 2001 ident: WOS:000169047400011 article-title: Structure-activity relationships of 1,4-dihydro-(1H,4H)-quinoxaline-2,3-diones as N-methyl-D-aspartate (glycine site) receptor antagonists. 1. Heterocyclic substituted 5-alkyl derivatives publication-title: JOURNAL OF MEDICINAL CHEMISTRY – volume: 51 start-page: 6263 year: 2008 ident: WOS:000260102700004 article-title: A Copper(I)-Catalyzed 1,2,3-Triazole Azide-Alkyne Click Compound Is a Potent Inhibitor of a Multidrug-Resistant HIV-1 Protease Variant publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm800149m – volume: 18 start-page: 4310 year: 2010 ident: WOS:000278480900015 article-title: Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents publication-title: BIOORGANIC & MEDICINAL CHEMISTRY doi: 10.1016/j.bmc.2010.04.091 – volume: 44 start-page: 969 year: 1991 ident: WOS:A1991GM54900008 article-title: 6-(SUBSTITUTED METHYLENE)PENEMS, POTENT BROAD-SPECTRUM INHIBITORS OF BACTERIAL BETA-LACTAMASE .5. CHIRAL 1,2,3-TRIAZOLYL DERIVATIVES publication-title: JOURNAL OF ANTIBIOTICS – volume: 19 start-page: 759 year: 2009 ident: WOS:000262707000040 article-title: Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS doi: 10.1016/j.bmcl.2008.12.026 – volume: 53 start-page: 2757 year: 2010 ident: WOS:000276096300006 article-title: Exploring the Structural Requirements for Inhibition of the Ubiquitin E3 Ligase Breast Cancer Associated Protein 2 (BCA2) as a Treatment for Breast Cancer publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm901757t – volume: 18 start-page: 4868 year: 2008 ident: WOS:000259144900026 article-title: Synthesis of triazole-oxazolidinones via a one-pot reaction and evaluation of their antimicrobial activity publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS doi: 10.1016/j.bmcl.2008.07.087 – volume: 46 start-page: 1983 year: 2011 ident: WOS:000291118600004 article-title: 4 beta-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: Design, synthesis and biological evaluation publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2011.02.016 – volume: 21 start-page: 3637 year: 2011 ident: WOS:000291145900027 article-title: Novel EGFR inhibitors prepared by combination of dithiocarbamic acid esters and 4-anilinoquinazolines publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS doi: 10.1016/j.bmcl.2011.04.096 – volume: 48 start-page: 5644 year: 2005 ident: WOS:000231743000003 article-title: 4-Aryl-1,2,3-triazole: A novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm050408c – volume: 129 start-page: 487 year: 2011 ident: WOS:000291603900023 article-title: Gold(III)-dithiocarbamato anticancer agents: activity, toxicology and histopathological studies in rodents publication-title: INTERNATIONAL JOURNAL OF CANCER doi: 10.1002/ijc.25684 – volume: 21 start-page: 3074 year: 2011 ident: WOS:000290024200060 article-title: Synthesis and in vitro antitumor activity of new butenolide-containing dithiocarbamates publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS doi: 10.1016/j.bmcl.2011.03.029 – volume: 46 start-page: 1274 year: 2011 ident: WOS:000289048400031 article-title: The novel anti-tumor agents of 4-triazol-1,8-naphthalimides: Synthesis, cytotoxicity, DNA intercalation and photocleavage publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2011.01.050 – volume: 45 start-page: 1435 year: 2006 ident: WOS:000235628700022 article-title: Inhibitors of HIV-1 protease by using in situ click chemistry publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION doi: 10.1002/anie.200502161 – volume: 49 start-page: 1648 year: 2006 ident: WOS:000236005400016 article-title: Gold(III) dithiocarbamate derivatives for the treatment of cancer: Solution chemistry, DNA binding, and hemolytic properties publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm0509288 – volume: 41 start-page: 2596 year: 2002 ident: WOS:000176972000038 article-title: A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION – volume: 5 start-page: 971 year: 2007 ident: WOS:000244703800014 article-title: 1,2,3-Triazoles as peptide bond isosteres: synthesis and biological evaluation of cyclotetrapeptide mimics publication-title: ORGANIC & BIOMOLECULAR CHEMISTRY doi: 10.1039/b616751a – volume: 73 start-page: 287 year: 2008 ident: WOS:000252046600040 article-title: Conjugation of nucleosides and oligonucleotides by [3+2] cycloaddition publication-title: JOURNAL OF ORGANIC CHEMISTRY doi: 10.1021/jo702023s – volume: 8 start-page: 1128 year: 2003 ident: WOS:000187217100009 article-title: The growing impact of click chemistry on drug discovery publication-title: DRUG DISCOVERY TODAY – volume: 9 start-page: 1571 year: 2001 ident: WOS:000169404600020 article-title: Dicationic dithiocarbamate carbapenems with anti-MRSA activity publication-title: BIOORGANIC & MEDICINAL CHEMISTRY – volume: 45 start-page: 4631 year: 2010 ident: WOS:000282112700027 article-title: Synthesis of novel sulfanilamide-derived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2010.07.031 – volume: 15 start-page: 6748 year: 2007 ident: WOS:000250179600014 article-title: Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry publication-title: BIOORGANIC & MEDICINAL CHEMISTRY doi: 10.1016/j.bmc.2007.08.020 – volume: 6 start-page: 2696 year: 2011 ident: WOS:000296273900010 article-title: Click Chemistry: 1,2,3-Triazoles as Pharmacophores publication-title: CHEMISTRY-AN ASIAN JOURNAL doi: 10.1002/asia.201100432 – volume: 55 start-page: 3911 year: 2012 ident: WOS:000303173600024 article-title: Design, Synthesis, and Structure-Activity Correlations of Novel Dibenzo[b,d]furan, Dibenzo[b,d]thiophene, and N-Methylcarbazole Clubbed 1,2,3-Triazoles as Potent Inhibitors of Mycobacterium tuberculosis publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm300125e – volume: 16 start-page: 9708 year: 2008 ident: WOS:000260758200009 article-title: Design, synthesis and antitumor evaluation of novel thalidomide dithiocarbamate and dithioate analogs against Ehrlich ascites carcinoma-induced solid tumor in Swiss albino mice publication-title: BIOORGANIC & MEDICINAL CHEMISTRY doi: 10.1016/j.bmc.2008.09.071 – volume: 10 start-page: 732 year: 2008 ident: WOS:000259033500020 article-title: Solution-phase parallel synthesis and biological evaluation of combretatriazoles publication-title: JOURNAL OF COMBINATORIAL CHEMISTRY doi: 10.1021/cc800090d – volume: 48 start-page: 1868 year: 2012 ident: WOS:000299112500008 article-title: Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations publication-title: CHEMICAL COMMUNICATIONS doi: 10.1039/c2cc16395k – volume: 14 start-page: 8644 year: 2006 ident: WOS:000242454700049 article-title: Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives publication-title: BIOORGANIC & MEDICINAL CHEMISTRY doi: 10.1016/j.bmc.2006.08.019 – volume: 24 start-page: 799 year: 1996 ident: WOS:A1996UW90000016 article-title: Identification and characterization of human metabolites of CAI[5-amino-1-1(4'-chlorobenzoyl-3,5-dichlorobenzyl)-1,2,3-triazole-4-carboxamide) publication-title: DRUG METABOLISM AND DISPOSITION – volume: 54 start-page: 1565 year: 2011 ident: WOS:000288400700003 article-title: Structure-Based Discovery of Inhibitors of Microsomal Prostaglandin E-2 Synthase-1, 5-Lipoxygenase and 5-Lipoxygenase-Activating Protein: Promising Hits for the Development of New Anti-inflammatory Agents publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm101238d – volume: 44 start-page: 2856 year: 1996 ident: WOS:A1996VH80700074 article-title: Synthesis and antifungal activity of novel bis(dithiocarbamate) derivatives of glycerol publication-title: JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY – volume: 26 start-page: 251 year: 1983 ident: WOS:A1983PZ65200025 article-title: STUDIES ON V-TRIAZOLES .7. ANTI-ALLERGIC 9-OXO-1H,9H-BENZOPYRANO[2,3-D]-V-TRIAZOLES publication-title: JOURNAL OF MEDICINAL CHEMISTRY – volume: 18 start-page: 2043 year: 2008 ident: WOS:000254180300055 article-title: Synthesis and antimicrobial activity of beta-lactam-bile acid conjugates linked via triazole publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS doi: 10.1016/j.bmcl.2008.01.102 – volume: 83 start-page: 1005 year: 2011 ident: WOS:000291084400002 article-title: SYNTHESIS OF VARIOUS SUBSTITUTED SPIRO- AND BICYCLETHIAZOLIDINE-2-THIONES BY A MULTICOMPONENT REACTION AND BIOLOGICAL EVALUATION IN VITRO publication-title: HETEROCYCLES doi: 10.3987/COM-11-12147 |
SSID | ssj0005600 |
Score | 2.5195024 |
Snippet | A series of novel 1,2,3-triazole-dithiocarbamate hybrids were designed, synthesized and evaluated for anticancer activity against four selected human tumor... |
Source | Web of Science |
SourceID | proquest pubmed webofscience crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 11 |
SubjectTerms | Antineoplastic Agents - chemical synthesis Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Apoptosis - drug effects Cell Cycle - drug effects Cell Line, Tumor Cell Proliferation - drug effects Chemistry, Medicinal Dose-Response Relationship, Drug Drug Design Drug Screening Assays, Antitumor Humans Life Sciences & Biomedicine MCF-7 Cells Molecular Structure Pharmacology & Pharmacy Science & Technology Structure-Activity Relationship Thiocarbamates - chemical synthesis Thiocarbamates - chemistry Thiocarbamates - pharmacology Triazoles - chemical synthesis Triazoles - chemistry Triazoles - pharmacology |
Title | Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents |
URI | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000318577500002 https://www.ncbi.nlm.nih.gov/pubmed/23353743 https://www.proquest.com/docview/1325331750 |
Volume | 62 |
WOS | 000318577500002 |
WOSCitedRecordID | wos000318577500002 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZ97C9jK271LuhQelLomBLURw9jqyjFDYKyyB7MrIsrw2pHRJnkD7st-_oYjtbUtYNEhPkG8n35ejo-JzvIHScZ1yxSCsiuSnJ4UoQoQUjVOU8DrOYUmEKnD99Hp59HZxP-bTTWWxlLa2rtK9u9taV_A-qMAa4mirZf0C2uSgMwGfAF7aAMGzvhPEHm35h4_-rTQGunFcXKcofet4FGzWm8GbEtOa4KeeamAqMK5i9lqkET1V3LzemYGtlms0sysokDlnpABPfBjIsu_J7LfW0N3rvPVn_fN4ojdTt41r_2AVYv8EMScaXsmwj4Ha4tMPaT5_bAezThrVfbN_h7vRKluS8nml9oMI0jWjyW7QzrrC0IYw60eja-npb7Myns7s7Vt0FGGZ9PbvW9glSRG0M1wUvt4BeXFukKWOcxU7-6Q817XrXPXSfwsLC9Lzo_9xKCgL_ry6wtFmAu7c08tH-Ir_7MjsLlL2-jPVbJo_RI7_gwO8de56gji4O0YNxDdQhOrlw6uWbHp60xXirHj7BF62u-eYpUo5uGOiGG7rhMseWbjjq0d7tVMOealiucEM13FINO6o9Q5OPp5PxGfE9OohiMavIMMzyMEuH4WigBI25NApq4ENKFg0yoXOWjViaRbHW4PeomKlRKjOtBqmQIzGS7Dk6KMpCHyHMFDjzaQ4etxIDLoRUmeI0hGM4FREdBojVP3aivH69aaMyT-pExVni0EoMWgm8AK0AkeashdNv-cvx72ocE8DBPD2ThS7XqyQC5jLjbYcBeuEAbq5YEyJAx9uIN_tDO3fyODbtR0IaoOguh439tzTqFNXLW2_6Cj1s_26v0UG1XOs34ClX6VtL7l-vn73Q |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design+and+synthesis+of+novel+1%2C2%2C3-triazole-dithiocarbamate+hybrids+as+potential+anticancer+agents&rft.jtitle=European+journal+of+medicinal+chemistry&rft.au=Duan%2C+Ying-Chao&rft.au=Ma%2C+Yong-Cheng&rft.au=Zhang%2C+En&rft.au=Shi%2C+Xiao-Jing&rft.date=2013-04-01&rft.eissn=1768-3254&rft.volume=62&rft.spage=11&rft_id=info:doi/10.1016%2Fj.ejmech.2012.12.046&rft_id=info%3Apmid%2F23353743&rft.externalDocID=23353743 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0223-5234&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0223-5234&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0223-5234&client=summon |